Search results

Order by most recent / most popular / relevance

Results: 1-10 of 730

Two recent US court decisions deal with the boundaries of patent law in the area of food technologies and computer systems

Bereskin & Parr LLP
-
Canada
-
May 21 2013

The US Federal Circuit Court of Appeals and US Supreme Court have both issued important decisions this week on the scope of US patent law. Ten (10

Patent exhaustion does not allow a purchaser to make new copies of patented seeds

Fasken Martineau DuMoulin LLP
-
Canada
-
May 16 2013

In a concise unanimous decision1, the Supreme Court of the United States has ruled in favor of Monsanto against a farmer who reproduced patented

Supreme Court declines to hear Eli Lilly’s “promise of the patent” appeal

Bereskin & Parr LLP
-
Canada
-
May 16 2013

The Supreme Court of Canada denied leave to appeal today from the Federal Court of Appeal ("FCA") decision in Eli Lilly Canada Inc v Novopharm Ltd

What goes upmust come down: Viagra patent invalidated by Canadian Supreme Court

Drinker Biddle & Reath LLP
-
Canada
-
May 13 2013

Pfizer and Teva have been fighting a legal battle over Pfizer's patent for Viagra in Canada. The first shot was fired when Novopharm Limited, now

Supreme Court of Canada denies leave to appeal in PM(NOC) judicial comity case

Bereskin & Parr LLP
-
Canada
-
May 9 2013

The Supreme Court of Canada denied leave to appeal today from the Federal Court of Appeal ("FCA") decision in Allergan Inc. et al ats. Apotex Inc

Teva Canada Innovation v. Attorney General of Canada

Borden Ladner Gervais LLP
-
Canada
-
May 8 2013

The Patented Medicine Prices Review Board (the PMPRB) ordered Teva to pay the Crown approximately $2.4 million for selling its product at an

Charting the phenomenal success of the Patent Prosecution Highway in Canada

Smart & Biggar/Fetherstonhaugh
-
Canada
-
May 7 2013

The Patent Prosecution Highway (PPH) program has been a phenomenal success in Canada and has positioned the country as a highly cost-effective

USTR slams Canada over the treatment of pharmaceutical patents

Norton Rose Canada LLP
-
Canada
-
May 6 2013

On May 1, 2013, the United States Trade Representative (“USTR”) released its annual IP report for 2013. Canada has been placed on the “Watch List"

Federal court rejects PMPRB Copaxone decision on excessive prices again

Gowling Lafleur Henderson LLP
-
Canada
-
May 3 2013

By a decision of Justice Zinn dated April 30, 2013, the Federal Court quashed a Board's decision on excessive pricing of Copaxone - for the second

Commissioner of Patents reverses examiner’s refusal to allow patent on basis of sound prediction and desired result arguments

Borden Ladner Gervais LLP
-
Canada
-
May 1 2013

The Application was rejected by the Examiner under section 2 of the Patent Act for containing claims for which the utility could not soundly be

next >

Search results

Two recent US court decisions deal with the boundaries of patent law in the area of food technologies and computer systems

Patent exhaustion does not allow a purchaser to make new copies of patented seeds

Supreme Court declines to hear Eli Lilly’s “promise of the patent” appeal

What goes upmust come down: Viagra patent invalidated by Canadian Supreme Court

Supreme Court of Canada denies leave to appeal in PM(NOC) judicial comity case

Teva Canada Innovation v. Attorney General of Canada

Charting the phenomenal success of the Patent Prosecution Highway in Canada

USTR slams Canada over the treatment of pharmaceutical patents

Federal court rejects PMPRB Copaxone decision on excessive prices again

Commissioner of Patents reverses examiner’s refusal to allow patent on basis of sound prediction and desired result arguments

Current Search

Suggested Facets

Author

Firm Name

Jurisdiction

Workarea